Zeria Pharmaceutical Co Ltd 4559
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 2,057.00
- Day Range
- JPY 2,056.00–2,072.00
- 52-Week Range
- JPY 1,880.00–2,600.00
- Bid/Ask
- JPY 2,061.00 / JPY 2,067.00
- Market Cap
- JPY 90.94 Bil
- Volume/Avg
- 26,900 / 76,841
Key Statistics
- Price/Earnings (Normalized)
- 11.19
- Price/Sales
- 1.22
- Dividend Yield (Trailing)
- 2.14%
- Dividend Yield (Forward)
- 2.14%
- Total Yield
- 2.29%
Company Profile
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,872
- Website
- http://www.zeria.co.jp
Comparables
Valuation
|
Metric
|
4559
|
4886
|
4554
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.19 | 13.71 | 7.56 |
Price/Book Value | 1.16 | 1.04 | 0.90 |
Price/Sales | 1.22 | 1.01 | 0.91 |
Price/Cash Flow | 6.24 | 8.12 | 3.91 |
Price/Earnings
4559
4886
4554
Financial Strength
|
Metric
|
4559
|
4886
|
4554
|
|---|---|---|---|
Quick Ratio | 0.79 | 1.80 | 0.68 |
Current Ratio | 1.09 | 2.88 | 1.46 |
Interest Coverage | 26.38 | 198.84 | 55.27 |
Quick Ratio
4559
4886
4554
Profitability
|
Metric
|
4559
|
4886
|
4554
|
|---|---|---|---|
Return on Assets (Normalized) | 7.07% | 6.19% | 3.39% |
Return on Equity (Normalized) | 14.28% | 9.87% | 7.02% |
Return on Invested Capital (Normalized) | 8.30% | 7.91% | 4.22% |
Return on Assets
4559
4886
4554
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Mlydqqbyc | Rgvlcf | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Lzqkftpdt | Hvfm | $68.3 Bil | |
HLN
| Haleon PLC ADR | Qwntlsslw | Ztz | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gwprrxq | Hjxv | $14.5 Bil | |
VTRS
| Viatris Inc | Rfmlcmfp | Fvgd | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jwsgbjwtb | Wxfx | $11.9 Bil | |
CTLT
| Catalent Inc | Cmslycbx | Syvpq | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Cpbmqrh | Hfs | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Zjqpdqxh | Wftb | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jnhykcltj | Gxcwgl | $3.5 Bil |